Table 2.
Comparison of the demographic, clinical and laboratory features of the patients who were followed up as outpatients and who were hospitalized
| Patients with RTI followed up as outpatients (n=106) | Patients with RTI who were hospitalized (n=34) | p | |
|---|---|---|---|
| Age, median (the lowest-the highest) | 5.5 (2.5–16) | 3.8 (2.5–15) | 0.045 |
| Gender, male/female n (%) | 61/45 (57/42.5) | 21/13 (61.8/38.2) | 0.664 |
| Age group, n (%) | |||
| 2–5 years | 48 (45.3) | 21 (61.8) | 0.094 |
| >5 years | 58 (54.7) | 13 (38.2) | |
| Indoor exposure to smoking, n (%) | 38 (35.8) | 8 (23.5) | 0.183 |
| Presence of underlying disease, n (%) | 16 (15.1) | 12 (35.3) | 0.01 |
| Symptom time, days, median (the lowest-the highest) | 3 (0–10) | 2 (1–7) | 0.027 |
| Virus distribution*, n (%) | |||
| Influenza A | 35 (33) | 12 (35.3) | 0.971 |
| Influenza B | 20 (18.9) | 3 (8.8) | 0.267 |
| RV | 10 (9.4) | 0 | 0.118 |
| RSV | 8 (7.5) | 5 (14.7) | 0.305 |
| HMPV | 8 (7.5) | 0 | 0.199 |
| KV | 6 (5.7) | 4 (11.8) | 0.256 |
| HBoV | 6 (5.7) | 2 (5.9) | 1.00 |
| PIV | 5 (4.7) | 0 | 0.335 |
| AV | 5 (4.7) | 6 (17.6) | 0.25 |
| Multiple infection | 2 (1.9) | 2 (5.9) | 0.248 |
| Laboratory, median (the lowest-the highest) | |||
| Leukocytes | 8 000 (3 020–25 500) | 10 700 (3 500–31 390) | 0.016 |
| Neutrophils | 4 000 (740–23 200) | 7 095 (700–27 720) | 0.006 |
| Lymphocytes | 2 170 (550–10 470) | 2 265 (450–4 600) | 0.782 |
| Neutrophil/lymphocyte | 2.05 (0.29–20.59) | 3.28 (0.15–22.53) | 0.015 |
| Eosinophil | 50 (0–1 000) | 10 (0–200) | 0.004 |
| CRP | 7 (0–71) | 20 (0–200) | <0.001 |
AV: adenovirus; CRP: C reactive protein; CV: coronavirus; HBoV: human bocavirus; HMPV: human metapneumovirus; n: number; PIV: parainfluenza virus; RSV: respiratory syncitial virüs; RV: rhinovirus; RTI: respiratory tract infection
*
P values in virus distribution were obtained by comparing the numbers of each virus found in the patients who were followed up as outpatients and who were hospitalized using chi-square test.